December 12, 2024 20:31 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal
India gets its first covid nasal vaccine iNCOVACC manufactured by Bharat Biotech

India gets its first covid nasal vaccine iNCOVACC manufactured by Bharat Biotech

Jan 26, 2023, at 10:11 pm

New Delhi/IBNS: Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh Thursday launched the world's first COVID-19 intranasal vaccine, iNCOVACC.

Govt approved Bharat Biotech's nasal anti-Covid vaccine: Reports

Govt approved Bharat Biotech's nasal anti-Covid vaccine: Reports

Dec 23, 2022, at 05:24 pm

New Delhi/IBNS/UNI: The central government has approved Bharat Biotech's nasal vaccine against Covid-19 amid the fresh scare of a surge in infections, media reports said.

Bharat Biotech's 1st nasal COVID vaccine gets approval for phase 2 trial

Bharat Biotech's 1st nasal COVID vaccine gets approval for phase 2 trial

Aug 14, 2021, at 02:49 am

New Delhi/IBNS: Bharat Biotech has received phase 2 human clinical trial nod for its nasal COVID vaccine, called BBV154, the Union Government informed on Friday.

Nasal vaccine against COVID-19 prevents infection in mice: Study

Nasal vaccine against COVID-19 prevents infection in mice: Study

Aug 23, 2020, at 03:19 am

Washignton: Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus.